Cannabis Bioscience International Holdings, Inc. 10-Q/A

Item 5. Other Information. Insider Trading Arrangements and Related Disclosure During the three months ended November 30, 2024, none of our directors or officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K. 24 Item 6. Exhibits. Exhibit Number Title 31 Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer and Principal Accounting Officer * 32 Section 1350 Certification of Principal Executive Officer and Principal Accounting Officer * 101.INS Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) * 101.SCH Inline XBRL Taxonomy Extension Schema Document * 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document * 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document * 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document * 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document * 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * ____________ * Filed herewith 25 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this amended report to be signed on its behalf by the undersigned thereunto duly authorized. CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. Date: January 24, 2025 By: /s/ Dante Picazo Dante Picazo Principal Executive Officer and Principal Accounting Officer 26